TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year January 11, 1991
TCL Archive Fisher, Bonadonna Studies Still Fuel DeVita’s Optimism; Carbon Lists Six Basic Research Needs July 15, 1977
TCL Archive Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds June 29, 2007
TCL Archive Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology. September 7, 2007
